Antiepileptic — GABA Transaminase Inhibitor
Pregnancy: Avoid — limited data; supplement folate
Vigabatrin
Brand names: Sabril
Adult dose
Dose: 1 g twice daily; increase by 500 mg/week; maintenance 2–3 g/day
Route: Oral
Frequency: Twice daily
Max: 3 g/day
Irreversibly inhibits GABA transaminase — increases brain GABA levels. Adjunctive therapy for refractory focal epilepsy. First-line for infantile spasms (West syndrome) in combination with pyridoxine. USE RESTRICTED — causes permanent visual field defects in 30–50% of adult patients.
Paediatric dose
Dose: 40–50 mg/day/kg
Route: Oral
Frequency: Twice daily
Max: 150 mg/kg/day
Infantile spasms (West syndrome): 50–150 mg/kg/day in 2 divided doses — first-line (with ACTH/corticosteroids). Focal epilepsy in children: 40–80 mg/kg/day.
Dose adjustments
Renal
Reduce dose: 50% reduction if eGFR 10–50; 75% if eGFR <10.
Hepatic
No specific adjustment.
Paediatric weight-based calculator
Infantile spasms (West syndrome): 50–150 mg/kg/day in 2 divided doses — first-line (with ACTH/corticosteroids). Focal epilepsy in children: 40–80 mg/kg/day.
Clinical pearls
- Visual field defects are IRREVERSIBLE — monitor every 6 months with Goldmann perimetry. Discontinue if defects detected. Inform DVLA.
- Infantile spasms: vigabatrin is first-line particularly for tuberous sclerosis — superior to corticosteroids in TSC-associated West syndrome
- Risk-benefit: use only for West syndrome (infantile spasms) or refractory focal epilepsy where benefits outweigh the visual field risk
Contraindications
- Pre-existing visual field defects
- Patients unable to attend visual field monitoring
Side effects
- Permanent visual field constriction (30–50% of adults — bilateral concentric narrowing)
- Sedation
- Weight gain
- Behavioural disturbance (especially in children — agitation, aggression)
- MRI signal changes (infantile spasms — reversible)
Interactions
- Phenytoin (reduces phenytoin levels by 20–30%)
- Clonazepam (additive CNS depression)
Monitoring
- Ophthalmology visual field assessment every 6 months (Goldmann perimetry)
- Seizure control
- Behavioural assessment in children
Reference: BNFc; BNF 90; NICE NG217; BNFc; MHRA Vigabatrin Visual Field Guidance. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- SMART Risk Score for Recurrent CVD · Cardiovascular Risk
- PCSK9 Inhibitor Eligibility Assessment · Lipid Management
- Immune-Related Adverse Events (irAE) -- GI Toxicity Colitis Grading · Oncology-Related GI
- irAE Hepatitis Grading (CTCAE) · Immunotherapy
- DIPSS — Dynamic International Prognostic Scoring System for Myelofibrosis · Cancer Prognosis
- BALL Score for Relapsed/Refractory CLL · Leukaemia
Pathways
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Suspected Subarachnoid Haemorrhage · NICE NG228; RCEM 2023; AHA/ASA 2023
- Adult Head Injury · NICE NG232 (2023)
- Bell's Palsy / Facial Nerve Palsy · ENT UK 2017; AAN
- Vertigo Workup · ENT UK; NICE CKS